Predicted Trait | |
Reported Trait | Preeclampsia |
Mapped Trait(s) | preeclampsia (EFO_0000668) |
Score Construction | |
PGS Name | pe |
Development Method | |
Name | PRS-CS |
Parameters | NR |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 1,102,059 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000574 |
Citation (link to publication) | Nurkkala J et al. J Hypertens (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation | European: 100% 2 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 33239696 |
[ ,
0.0 % Male samples |
European, Central Asian | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM020743 | PSS011387| European Ancestry| 138,317 individuals |
PGP000574 | Nurkkala J et al. J Hypertens (2022) |
Reported Trait: Gestational hypertension | HR: 1.16 [1.14, 1.19] | — | — | Collection year, genotyping batch, and the first 10 genetic principal components | — |
PPM020744 | PSS011388| European Ancestry| 136,354 individuals |
PGP000574 | Nurkkala J et al. J Hypertens (2022) |
Reported Trait: Preeclampsia | HR: 1.21 [1.18, 1.24] | — | — | Collection year, genotyping batch, and the first 10 genetic principal components | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011387 | — | — | [ ,
0.0 % Male samples |
— | European (Finnish) |
— | FinnGen | — |
PSS011388 | — | — | [ ,
0.0 % Male samples |
— | European (Finnish) |
— | FinnGen | — |